Mengling Chang
Impact in
- Rehabilitation top 5%
- Wound Healing and Treatments
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications
Papers in
- Surgery 5
- Tissue Engineering and Regenerative Medicine 2
- Co-authors
- Q. N. Xu (2 shared papers)Endian Wang (2 shared papers)Zhiguang Huan (2 shared papers)Jiang Chang (2 shared papers)Min Xing (2 shared papers)Zengding Zhou (10 shared papers)Lei Yi (7 shared papers)Feng Bao (1 shared paper)
In The Last Decade
Mengling Chang
23 papers receiving 567 citations
Peers
Comparison fields: 5 of 97
- Rehabilitation 155
- Biomaterials 125
- Urology 29
- Renewable Energy, Sustainability and the Environment 66
- Critical Care and Intensive Care Medicine 19
Countries citing papers authored by Mengling Chang
This map shows the geographic impact of Mengling Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengling Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengling Chang more than expected).
Fields of papers citing papers by Mengling Chang
This network shows the impact of papers produced by Mengling Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengling Chang. The network helps show where Mengling Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengling Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 126 | |
| 2 | 2020 | 121 | |
| 3 | 2023 | 61 | |
| 4 | 2019 | 51 | |
| 5 | 2016 | 27 | |
| 6 | Propranolol enhanced adipogenesis instead of induction of apoptosis of hemangiomas stem cells. | 2014 | 23 |
| 7 | 2017 | 20 | |
| 8 | 2015 | 20 | |
| 9 | 2022 | 19 | |
| 10 | 2019 | 18 | |
| 11 | 2017 | 17 | |
| 12 | 2019 | 14 | |
| 13 | Successful treatment of Kimura's disease with leflunomide and methylprednisolone: a case report. | 2014 | 11 |
| 14 | 2017 | 10 | |
| 15 | 2022 | 9 | |
| 16 | Combination of propranolol and sclerotherapy for treatment of infantile parotid hemangiomas. | 2015 | 5 |
| 17 | 2022 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 3 |
About Mengling Chang
Mengling Chang is a scholar working on Molecular Biology, Surgery, Rehabilitation, Biomaterials and Oncology, having authored 25 papers that have together received 573 indexed citations. Recurring topics across this work include Electrospun Nanofibers in Biomedical Applications (5 papers), Wound Healing and Treatments (5 papers), Dermatologic Treatments and Research (2 papers), Mesenchymal stem cell research (2 papers), Vascular Tumors and Angiosarcomas (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Sulfur Compounds in Biology (2 papers) and Burn Injury Management and Outcomes (2 papers). The work is most often cited by research in Rehabilitation (155 citations), Biomaterials (125 citations), Urology (29 citations), Renewable Energy, Sustainability and the Environment (66 citations) and Critical Care and Intensive Care Medicine (19 citations). Mengling Chang has collaborated with scholars based in China and Taiwan. Frequent co-authors include Q. N. Xu, Endian Wang, Zhiguang Huan, Jiang Chang, Min Xing, Zengding Zhou, Lei Yi, Feng Bao, Feng Guo and Yu Zhang. Their work appears in journals such as Plastic & Reconstructive Surgery, Frontiers in Cellular and Infection Microbiology, Biomedical Materials, Frontiers in Bioengineering and Biotechnology and ChemSusChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.